Unbranded advertising of prescription medicines to the public by pharmaceutical companies

Teresa Meneses Leonardo Alves, Aukje K. Mantel-Teeuwisse, Anne Paschke, Hubert G.M. Leufkens, Lorri Puil, Elita Poplavska, Barbara Mintzes

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of unbranded advertising of prescription medicines, conducted by or on behalf of pharmaceutical companies, on consumers' attitudes, knowledge, behaviour, health services use, health outcomes and costs.

Original languageEnglish
Article numberCD012699
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number7
DOIs
Publication statusPublished - 10 Jul 2017

Fingerprint

Dive into the research topics of 'Unbranded advertising of prescription medicines to the public by pharmaceutical companies'. Together they form a unique fingerprint.

Cite this